Amylin Pharmaceuticals Inc. (AMLN) Stock Quote

Detailed Quote for Amylin Pharmaceuticals Inc. (AMLN)

After Hours: $ 17.18

0.01 (+0.06%)

Volume: 7.32 k

5:56 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

February 3, 2012

Close: 18.30

52 Week Low

October 4, 2011

Close: 8.03

Today

Last Price
17.17

Change $
0.12

Change %
0.70%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
16.61

High
17.27

Low
16.60

Prev Close
17.05

Last Trade
2/10/12

Volume
3.33 m

52 Wk Hi
18.30

52 Wk Low
8.03

Market Cap
2.51 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
146,283,002

EPS (TTM)
-3.73

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Amylin Pharmaceuticals Inc. (AMLN)

Sector News | Topic News

News for AMLN

Thu, Feb 09, 2012

4:15 PM

Amylin Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference - PR Newswire

9:00 AM

A Forward Look, the Year Ahead - Featured Research on BioMarin Pharmaceutical Inc. and Amylin Pharmaceuticals, Inc. - Marketwire

Mon, Feb 06, 2012

4:41 PM

Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results - PR Newswire

Mon, Jan 30, 2012

4:15 PM

Amylin Pharmaceuticals to Webcast 2011 Year-End Financial Results - PR Newswire

Fri, Jan 27, 2012

3:39 PM

FDA Approves BYDUREON(tm) -- The First and Only Once-Weekly Treatment for Type 2 Diabetes - PR Newswire

Mon, Jan 09, 2012

5:05 PM

Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates - PR Newswire

Tue, Jan 03, 2012

8:00 AM

Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference - PR Newswire

Wed, Nov 23, 2011

4:15 PM

Amylin Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Healthcare Conference - PR Newswire

Fri, Nov 11, 2011

9:00 AM

Europe Situation Forecasts Change -- Report Highlights Amylin Pharmaceuticals, Inc. and priceline.com Incorporated - Marketwire

Wed, Nov 09, 2011

8:00 AM

Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 Healthcare Conference - PR Newswire

Tue, Nov 08, 2011

6:30 AM

Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin - PR Newswire

Mon, Nov 07, 2011

7:01 AM

From the Needle to the Pill: How Biotechnology Breakthough Can Help Patients, Doctors and Insurers Huge Costs - Accesswire

Wed, Nov 02, 2011

4:15 PM

Amylin Pharmaceuticals to Present at the Credit Suisse 2011 Healthcare Conference - PR Newswire

8:16 AM

Optimism on Diabetes Medication Grows -- MannKind and Amylin Benefit - Marketwire

Wed, Oct 19, 2011

6:10 PM

BYETTA® Approved for Use with Insulin Glargine in the U.S. - PR Newswire

4:05 PM

Amylin Pharmaceuticals Reports Third Quarter Financial Results - PR Newswire

Wed, Oct 12, 2011

4:15 PM

Amylin Pharmaceuticals to Webcast Third Quarter Results - PR Newswire

Mon, Sep 12, 2011

7:00 AM

Analyses Find Type 2 Diabetes Patients Treated with BYDUREON(tm) Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 - PR Newswire

Wed, Sep 07, 2011

4:15 PM

Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference - PR Newswire

Thu, Jul 07, 2011

8:16 AM

MannKind and Amylin Embrace the Future of Diabetes Treatment - Marketwire

More News for AMLN >>

Tags for Amylin Pharmaceuticals Inc.

Research stocks or mutual funds related to Amylin Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to AMLN. The keywords below have been associated to AMLN by either user submission or electronic means.

diabetes handbook biotech research pharmaceuticals research pharmaceutical branding pharmaceutical industry strategy pharmaceutical market Commercial Physical And Biological Research (8731) generic pharmaceutical pharmaceutical investment clinical research consulting pharmaceutical research and development pharmaceutical manufacturing company pharmaceutical advisory boards pharmaceutical industry marketing research development agreements pharmaceutical software pharma manufacturing pharmaceutical clinical research pfizer pharmaceutical company kv pharmaceutical company gmp pharmaceutical pharmaceutical cro biopharmaceutical companies pharma consulting pharmaceutical sales exendin 4 biotech corporation biopharmaceutical company biotech incretin Drugs pharma r&d pharmaceutical industry news biotech industry research pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation company research pharmaceutical article pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting pharmaceutical industry biopharmaceutical market clinical trials europe pharmaceutical studies pharmaceutical strategy patent research pharmaceutical advances pharmaceutical out licensing